NORTHVALE, NJ / ACCESSWIRE / May 3, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today
/PRNewswire/ The "Rare Neurological Disease Treatment Market - Growth, Trends, and Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com s.